FDA Warning Letter — Akorn, Inc.

Case 362738 — FEI 3003102962

The FDA took a Warning Letter action against Akorn, Inc. on Oct 2, 2012 (Gurnee, IL). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Akorn, Inc.
Date
Oct 2, 2012
Fiscal Year
2013
Product Type
Drugs
Center
CDER
Location
Gurnee, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.